Filing Details

Accession Number:
0001209191-18-038128
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-15 17:35:09
Reporting Period:
2018-06-13
Accepted Time:
2018-06-15 17:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591306 J John Kuch C/O Xencor, Inc.
111 West Lemon Avenue
Monrovia CA 91016
Sr. Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-06-13 25,000 $41.64 56,629 No 4 S Direct
Common Stock Acquisiton 2018-06-13 35,853 $4.25 92,482 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-06-13 35,853 $0.00 35,853 $4.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-09-03 No 4 M Direct
Footnotes
  1. The weighted average sale price for the transaction reported was $41.6378, and the range of prices were between $41.50 and $41.965. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  2. Includes 2,084 shares of Common Stock that were acquired by the Reporting Person on June 9, 2017, 1,800 shares of Common Stock that were acquired by the Reporting Person on December 15, 2017 and 574 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
  3. The stock option is fully vested and exercisable.